| For: | Elmati PR, Jagirdhar GSK, Surani S. Cardiac implications in myasthenia gravis. World J Clin Cases 2024; 12(26): 5863-5867 [PMID: 39286385 DOI: 10.12998/wjcc.v12.i26.5863] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v12/i26/5863.htm |
| Number | Citing Articles |
| 1 |
Hongxia Yang, Zulin Pan, Ying Yang, Yaxuan Wang, Biqi Cheng, Guoyan Qi. Case report: Efgartigimod combined with intravenous methylprednisolone in a case of co-occurrence of unexplained myasthenia gravis, inflammatory myopathy, and fulminant myocarditis. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1769065
|
| 2 |
Christian Messina. The overlooked side of myasthenia gravis: the non-motor manifestations—a comprehensive review. Journal of Neurology 2025; 272(12) doi: 10.1007/s00415-025-13504-3
|
| 3 |
Kelly G. Gwathmey, Catherine M. Broome, Matthias Goebeler, Hiroyuki Murai, Zsuzsanna Bata-Csörgo, Adrian C. Newland, Jeffrey A. Allen, Yoshitaka Miyakawa, Peter Ulrichts, Luc Truyen, Jana Podhorna, Rene Kerstens, Sophie Steeland, Jon Beauchamp, Jeffrey T. Guptill, James F. Howard. Safety profile of efgartigimod from global clinical trials across multiple immunoglobulin G-mediated autoimmune diseases. Expert Review of Clinical Immunology 2025; 21(5): 627 doi: 10.1080/1744666X.2025.2497840
|
| 4 |
Benjamin Beland, Min Kang, Priya Dhawan, Pritikanta Paul. Optimising well-being in myasthenia gravis: a multidisciplinary approach. Practical Neurology 2026; 26(3): 216 doi: 10.1136/pn-2025-004656
|
| 5 |
Po-Chih Chen, Jakir Hossain Bhuiyan Masud, Chen-Chih Chung. Associations between myasthenia Gravis and outcomes following cardiac surgery: an analysis of the nationwide inpatient sample. BMC Anesthesiology 2026; 26(1) doi: 10.1186/s12871-026-03676-4
|